Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · BILL · 115th Congress · H.R. 2851 (Introduced in House) — To amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, and for oth... · Sec. 2

Sec. 2. Establishment of Schedule A

389 words·~2 min read·/bill/115/hr/2851/ih/section-2·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 202 of the Controlled Substances Act ( 21 U.S.C. 812 ) is amended— in subsection (a), by striking five schedules of controlled substances, to be known as schedules I, II, III, IV, and V and inserting six schedules of controlled substances, to be known as schedules I, II, III, IV, V, and A ; in subsection (b), by adding at the end the following: The drug or substance— has— a chemical structure that is substantially similar to the chemical structure of a controlled substance in schedule I, II, III, IV, or V; and an actual or predicted stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I, II, III, IV, or V; and is not— listed or otherwise included in any other schedule in this section or by regulation of the Attorney General; and with respect to a particular person, subject to an exemption that is in effect for investigational use, for that person, under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) to the extent conduct with respect to such substance is pursuant to such exemption.
For purpose of this paragraph, a predicted stimulant, depressant, or hallucinogenic effect on the central nervous system may be based on— the chemical structure, structure activity relationships, binding receptor assays, or other relevant scientific information about the substance; the current or relative potential for abuse of the substance; and the clandestine importation, manufacture, or distribution, or diversion from legitimate channels, of the substance; or the capacity of the substance to cause a state of dependence, including physical or psychological dependence that is similar to or greater than that of a controlled substance in schedule I, II, III, IV, or V. ; and in subsection (c)— in the matter preceding schedule I, by striking IV, and V and inserting IV, V, and A ; and by adding at the end the following:
(a)Unless specifically excepted or unless listed in another schedule, any of the following substances, as scheduled in accordance with section 201(k)(5): 4-fluoroisobutyryl fentanyl. Valeryl fentanyl. 4-methoxybutyryl fentanyl. 4-methylphenethyl acetyl fentanyl. 3-furanyl fentanyl. Ortho-fluorofentanyl. Tetrahydrofuranyl fentanyl. Ocfentanil. 4-fluorobutyryl fentanyl. Methoxyacetyl fentanyl. Meta-fluorofentanyl. Isobutyryl fentanyl. Acryl fentanyl. .
Connectionstraces to 2
Citation graph
cites case law
Sec. 2
Establishment of Schedule A
Cites 2Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.